Igentify

Company Overview

Snapshot

Founded in October 2016 by Doron Behar and Galit Delmar, Igentify operates with 51–200 employees. The company has raised $38.36 million across 8 funding rounds from 6 investors.

Business overview

Igentify is a digital health company that develops a digital platform for genetic test providers. Its core offering, the Digital Genetic Counselor, provides an end-to-end genetic counseling solution for both clinical and direct-to-consumer genetic testing applications. The platform supports various genotyping technologies, including microarray and next-generation sequencing, and delivers machine-generated personalized genetic counseling. Igentify operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, focusing on Medical Decision Support and Patient Engagement for healthcare providers, patients, and laboratories.

Strategic signal

In October 2022, Igentify released Version 7 of its Digital Genetic Engine, enhancing its capacity to scale genetic counseling to meet growing demand. This update signals Igentify's continued commitment to advancing its core technology and addressing market needs for efficient and accessible genetic testing solutions, indicating ongoing product development and market responsiveness to investors.

Company Intelligence Q&A

What significant product development did Igentify announce in October 2022?

In October 2022, Igentify released Version 7 of its Digital Genetic Engine, designed to scale genetic counseling to meet increasing demand.

When did Igentify announce new hires?

In June 2022, Igentify announced new hires, indicating growth in its team and operations.

What strategic collaboration did Igentify announce in November 2020?

In November 2020, Igentify announced a strategic collaboration with Genosity to integrate their offerings, aiming to provide a comprehensive precision medicine solution for health systems.